Authors’ reply

Belén Martíneza, Juan F. Martínezb, José R. Apariciob

Vinalopó University Hospital, Elche; Alicante University General Hospital, Isabial-Fisabio, Alicante, Spain

aDigestive Service, Vinalopó University Hospital, Elche (Belén Martínez), Spain; bEndoscopy Unit, Digestive Service, Alicante University General Hospital, Isabial-Fisabio, Alicante (Juan F. Martínez, José R. Aparicio), Spain

Correspondence to: Dr. José R. Aparicio Tormo, Unidad de Endoscopia, Digestiva, Hospital General Universitario de Alicante, Avda. Pintor, Baeza, sn, 03010 Alicante, Spain, e-mail: japariciot@gmail.com
Received 7 May 2018; accepted 7 May 2018; published online 19 June 2018
DOI: https://doi.org/10.20524/aog.2018.0286
© 2018 Hellenic Society of Gastroenterology

Ann Gastroenterol 2018; 31 (5): 637-638

Thank you very much for your comments which we entirely agree with. Those who perform endoscopic ultrasound (EUS) are accustomed to spotting lesions not seen in other imaging tests on a daily basis. A detailed examination of all structures visible by EUS, particularly of the pancreas, gives us the opportunity to detect lesions that can be treated in their early stages—especially cystic lesions of the pancreas. However, the detection of these lesions can significantly increase the demand for EUS in already overloaded endoscopy units. We sincerely believe that a standardization of the EUS procedure must be implemented.

Notes

Conflict of Interest: None